Lakefront Biotherapeutics NV (GLPG) Form 6-K — Jul 7, 2026
Lakefront Biotherapeutics NV executed its share repurchase program between June 29 and July 3, 2026, acquiring a total of 104,022 ordinary shares. The transactions were carried out across multiple trading venues including Euronext Amsterdam and Chi-X Europe. The company expended approximately €2.73 million on the buyback, paying an average price of €26.24 per share with individual prices ranging from €25.60 to €26.88. This activity is part of the repurchase framework initially announced by the company on June 9, 2026.
Key figures
- Average Price Eur
- 26.24
- Shares Repurchased
- 104022
- Treasury Shares Held
- 303756
- Price Range Eur
- 25.60 - 26.88
- Repurchase Period
- 2026-06-29 to 2026-07-03
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.